+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Coccidiosis Vaccines Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6120964
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Coccidiosis Vaccines Market is projected to reach USD 630.36 Million in 2026. It is expected to continue growing at a CAGR of 6.71%, reaching USD 915.37 Million by 2032.

Coccidiosis Vaccines: Executive Overview

Coccidiosis vaccines are biological tools used to reduce the impact of Eimeria infections in poultry and other susceptible livestock systems. Their relevance is linked to animal health, production continuity, antimicrobial stewardship, food safety, and the efficiency of intensive farming. Adoption depends on disease prevalence, production systems, veterinary oversight, regulatory requirements, cold-chain capability, and producer confidence in flock-level outcomes.

Production Systems Are Driving a Shift Toward Preventive Control

The landscape is shifting from reliance on therapeutic intervention toward integrated prevention that combines vaccination, biosecurity, litter management, nutrition, monitoring, and targeted treatment. This change is reinforced by concerns about antimicrobial resistance and by the operational cost of disease-related performance losses. Vaccine programs must increasingly fit different production cycles, species, housing systems, and farm-management practices while maintaining practical administration and consistent flock coverage.

Artificial Intelligence Strengthens Surveillance and Program Precision

Artificial intelligence can support coccidiosis control by analyzing flock performance, mortality, feed and water consumption, environmental conditions, lesion scores, diagnostic results, and treatment records. These tools may help identify abnormal patterns earlier, improve risk stratification, and guide sampling or veterinary review. Their value depends on reliable farm data, validated models, interoperability with production systems, and human oversight; AI should complement, rather than replace, laboratory diagnosis and veterinary judgment.

Regional Insights: Regulation, Production Structure, and Disease Pressure Differ

North America combines technologically advanced poultry production with structured veterinary oversight and strong attention to antimicrobial stewardship. Latin America’s large poultry sectors create substantial need for scalable prevention, while uneven infrastructure and diverse farm profiles affect implementation. Europe emphasizes regulatory compliance, animal welfare, traceability, and reduced antimicrobial use. The Middle East faces varied climatic and production conditions, making biosecurity and heat management important. Africa presents heterogeneous poultry systems, with access, cold-chain capacity, diagnostics, and producer education shaping uptake. Asia-Pacific includes highly diverse production environments, from sophisticated integrated operations to smallholder systems, requiring locally adaptable vaccination and surveillance approaches.

Group Insights: Economic and Regulatory Blocs Shape Adoption Conditions

ASEAN markets reflect rapid poultry-sector development alongside varied veterinary infrastructure, making adaptable delivery and producer training important. BRICS economies span major livestock producers with differing regulatory systems, disease priorities, and production structures. The European Union places strong emphasis on harmonized standards, animal health, welfare, and responsible antimicrobial use. G7 countries generally combine mature regulatory frameworks with advanced diagnostics and data-enabled production. GCC markets must account for climatic stress, import dependence, and concentrated food-production systems. NATO members represent diverse agricultural environments, but shared attention to resilience, biosecurity, and continuity of food supply supports preventive animal-health planning.

Country Insights: National Conditions Require Tailored Implementation

Australia’s extensive geography and biosecurity focus favor robust surveillance and logistics planning. Brazil’s intensive poultry industry requires programs compatible with large-scale integration and export-oriented controls. Canada and the United States combine sophisticated production systems with established veterinary services and strong antimicrobial-stewardship priorities. China and India require approaches suited to very large and diverse poultry populations, including differences between integrated farms and smaller producers. Japan and South Korea emphasize traceability, high production standards, and disease prevention. France, Germany, Italy, and Spain operate within European regulatory and welfare frameworks. The United Kingdom similarly emphasizes biosecurity, stewardship, and supply-chain assurance. Mexico’s varied production base makes regional implementation, training, and access to veterinary support especially relevant. Russia’s broad geography and domestic production priorities increase the importance of resilient supply and adaptable disease-control systems.

Action Priorities for Leaders: Integrate Vaccination With Measurable Flock Health

Industry leaders should begin with epidemiological assessment and define vaccination objectives by species, production system, and disease risk. Programs should be integrated with biosecurity, litter and moisture control, nutrition, diagnostics, and carefully governed treatment protocols. Management teams should establish measurable indicators such as mortality, weight uniformity, feed conversion, lesion findings, oocyst monitoring, and vaccine application quality. Investment in staff training, cold-chain assurance, digital records, and veterinary review can improve consistency. Leaders should also maintain regulatory alignment, document antimicrobial use, and evaluate program performance through controlled farm-level comparisons rather than relying on isolated observations.

Research Methodology: Evidence-Based Market Interpretation

This executive summary uses the defined market scope of coccidiosis vaccines and synthesizes established industry considerations across animal health, poultry production, veterinary practice, regulation, biosecurity, diagnostics, and antimicrobial stewardship. The analysis is organized by structural shifts and the required regional, group, and country geographies. It avoids market sizing, shares, forecasts, and unsupported numerical claims. Conclusions are framed as operational implications that should be validated against current regulatory documents, peer-reviewed evidence, field studies, diagnostic data, and producer-specific performance records.

Conclusion: Prevention, Data Quality, and Local Fit Will Define Progress

Coccidiosis vaccine programs are becoming more relevant within broader efforts to improve flock resilience and reduce dependence on routine antimicrobial intervention. Successful implementation will depend less on vaccination in isolation than on coordination with biosecurity, diagnostics, farm management, and credible performance measurement. Regional and national differences require tailored delivery models, while data and AI can improve surveillance when supported by quality records and expert oversight. Leaders that connect preventive health programs with measurable production and stewardship objectives will be better positioned to strengthen animal health and operational resilience.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Coccidiosis Vaccines Market, by Product Type
7.1. Introduction
7.2. Attenuated Live Vaccine
7.2.1. Precocious
7.2.2. Wild Type
7.3. Inactivated Vaccine
7.4. Recombinant Vaccine
7.5. Subunit Vaccine
7.6. Vector Vaccine
8. Coccidiosis Vaccines Market, by Animal Type
8.1. Introduction
8.2. Broiler Chickens
8.3. Layer Chickens
8.4. Turkeys
9. Coccidiosis Vaccines Market, by Administration Route
9.1. Introduction
9.2. Injection
9.3. Oral
9.3.1. In-Feed
9.3.2. In-Ovo
9.3.3. In-Water
10. Coccidiosis Vaccines Market, by Sales Mode
10.1. Introduction
10.2. Over-The-Counter
10.3. Prescription
11. Coccidiosis Vaccines Market, by End User
11.1. Introduction
11.2. Commercial Poultry Farms
11.3. Integrated Poultry Producers
11.4. Research Institutes
12. Coccidiosis Vaccines Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online Channels
13. Coccidiosis Vaccines Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Coccidiosis Vaccines Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Coccidiosis Vaccines Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Animalcare Group plc
17.2. APHA
17.3. BIMeda, Inc.
17.4. Bioproperties (Hubei) Biotechnology Co., Ltd.
17.5. Ceva Santé Animale S.A.
17.6. CEVAC
17.7. Elanco Animal Health Incorporated
17.8. Elanco Operations LLC
17.9. Hester Biosciences Limited
17.10. Huvepharma AD
17.11. IDT Biologika GmbH
17.12. ImmuCell Corporation
17.13. Indian Immunologicals Limited
17.14. Intervet International B.V.
17.15. Laboratorios Hipra, S.A.
17.16. Lohmann Animal Health International GmbH
17.17. Merck Sharp & Dohme Corp.
17.18. MSD Animal Health UK Limited
17.19. Pharmaq AS
17.20. Phibro Animal Health Corporation
17.21. The Chemo-Sero-Therapeutic Research Institute (Kaketsuken)
17.22. Vaxxinova International BV
17.23. Vetoquinol S.A.
17.24. Virbac S.A.
17.25. Zoetis Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Coccidiosis Vaccines Market, Years Considered for the Study
FIGURE 2. Global Coccidiosis Vaccines Market, Research Design
FIGURE 3. Global Coccidiosis Vaccines Market, Research Framework
FIGURE 4. Global Coccidiosis Vaccines Market, Data Triangulation
FIGURE 5. Global Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Coccidiosis Vaccines Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Coccidiosis Vaccines Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Coccidiosis Vaccines Market Size, by Animal Type, 2025 vs 2032 (%)
FIGURE 9. Global Coccidiosis Vaccines Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Coccidiosis Vaccines Market Size, by Administration Route, 2025 vs 2032 (%)
FIGURE 11. Global Coccidiosis Vaccines Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Coccidiosis Vaccines Market Size, by Sales Mode, 2025 vs 2032 (%)
FIGURE 13. Global Coccidiosis Vaccines Market Size, by Sales Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Coccidiosis Vaccines Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Coccidiosis Vaccines Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Coccidiosis Vaccines Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Coccidiosis Vaccines Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Coccidiosis Vaccines Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Coccidiosis Vaccines Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Coccidiosis Vaccines Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Coccidiosis Vaccines Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Coccidiosis Vaccines Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Coccidiosis Vaccines Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Coccidiosis Vaccines Market Segmentation & Coverage
TABLE 2. Global Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 3. Global Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Attenuated Live Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Attenuated Live Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Attenuated Live Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Precocious Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Precocious Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Precocious Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Wild Type Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Wild Type Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Wild Type Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Inactivated Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Inactivated Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Inactivated Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Recombinant Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Recombinant Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Recombinant Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Subunit Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Subunit Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Subunit Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Vector Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Vector Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Vector Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 26. Global Broiler Chickens Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Broiler Chickens Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Broiler Chickens Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Layer Chickens Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Layer Chickens Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Layer Chickens Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Turkeys Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Turkeys Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Turkeys Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 36. Global Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global In-Feed Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global In-Feed Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global In-Feed Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global In-Ovo Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global In-Ovo Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global In-Ovo Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global In-Water Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global In-Water Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global In-Water Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 52. Global Over-The-Counter Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Over-The-Counter Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Over-The-Counter Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Prescription Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Prescription Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Prescription Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. Global Commercial Poultry Farms Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Commercial Poultry Farms Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Commercial Poultry Farms Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Integrated Poultry Producers Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Integrated Poultry Producers Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Integrated Poultry Producers Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 69. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Online Channels Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Online Channels Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Online Channels Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Coccidiosis Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Coccidiosis Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 88. North America Coccidiosis Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. North America Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. North America Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 91. North America Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 92. North America Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 93. North America Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 94. North America Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 95. North America Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. North America Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. Latin America Coccidiosis Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Latin America Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. Latin America Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 100. Latin America Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 101. Latin America Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 102. Latin America Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 103. Latin America Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 104. Latin America Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Latin America Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. Europe Coccidiosis Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Europe Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. Europe Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 109. Europe Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 110. Europe Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 111. Europe Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 112. Europe Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 113. Europe Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Europe Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. Middle East Coccidiosis Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Middle East Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. Middle East Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 118. Middle East Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 119. Middle East Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 120. Middle East Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 121. Middle East Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 122. Middle East Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. Middle East Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 124. Africa Coccidiosis Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Africa Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. Africa Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 127. Africa Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 128. Africa Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 129. Africa Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 130. Africa Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 131. Africa Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. Africa Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 133. Global Coccidiosis Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. ASEAN Coccidiosis Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. ASEAN Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 136. ASEAN Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 137. ASEAN Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 138. ASEAN Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 139. ASEAN Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 140. ASEAN Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 141. ASEAN Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. ASEAN Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 143. GCC Coccidiosis Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. GCC Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. GCC Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 146. GCC Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 147. GCC Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 148. GCC Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 149. GCC Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 150. GCC Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. GCC Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. European Union Coccidiosis Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. European Union Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. European Union Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 155. European Union Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 156. European Union Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 157. European Union Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 158. European Union Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 159. European Union Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. European Union Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. BRICS Coccidiosis Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. BRICS Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. BRICS Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 164. BRICS Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 165. BRICS Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 166. BRICS Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 167. BRICS Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 168. BRICS Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. BRICS Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 170. G7 Coccidiosis Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. G7 Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 172. G7 Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 173. G7 Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 174. G7 Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 175. G7 Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 176. G7 Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 177. G7 Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. G7 Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. NATO Coccidiosis Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. NATO Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. NATO Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 182. NATO Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 183. NATO Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 184. NATO Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 185. NATO Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 186. NATO Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. NATO Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. Global Coccidiosis Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 189. United States Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 190. United States Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. United States Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 192. United States Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 193. United States Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 194. United States Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 195. United States Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 196. United States Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. United States Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 198. Canada Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 199. Canada Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 200. Canada Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 201. Canada Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 202. Canada Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 203. Canada Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 204. Canada Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 205. Canada Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Canada Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. Mexico Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 208. Mexico Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. Mexico Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 210. Mexico Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 211. Mexico Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 212. Mexico Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 213. Mexico Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 214. Mexico Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. Mexico Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 216. Brazil Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 217. Brazil Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. Brazil Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 219. Brazil Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 220. Brazil Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 221. Brazil Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 222. Brazil Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 223. Brazil Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. Brazil Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 225. United Kingdom Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 226. United Kingdom Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 227. United Kingdom Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 228. United Kingdom Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 229. United Kingdom Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 230. United Kingdom Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 231. United Kingdom Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 232. United Kingdom Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. United Kingdom Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. Germany Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 235. Germany Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 236. Germany Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 237. Germany Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 238. Germany Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 239. Germany Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 240. Germany Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 241. Germany Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Germany Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 243. France Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 244. France Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. France Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 246. France Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 247. France Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 248. France Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 249. France Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 250. France Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. France Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. Russia Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 253. Russia Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. Russia Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 255. Russia Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 256. Russia Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 257. Russia Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 258. Russia Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 259. Russia Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Russia Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 261. Italy Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 262. Italy Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 263. Italy Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 264. Italy Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 265. Italy Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 266. Italy Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 267. Italy Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 268. Italy Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Italy Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 270. Spain Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 271. Spain Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. Spain Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 273. Spain Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 274. Spain Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 275. Spain Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 276. Spain Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 277. Spain Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. Spain Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 279. China Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 280. China Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 281. China Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 282. China Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 283. China Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 284. China Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 285. China Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 286. China Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. China Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 288. India Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 289. India Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 290. India Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 291. India Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 292. India Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 293. India Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 294. India Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 295. India Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. India Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 297. Japan Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 298. Japan Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 299. Japan Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 300. Japan Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 301. Japan Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 302. Japan Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 303. Japan Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 304. Japan Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. Japan Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 306. Australia Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 307. Australia Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 308. Australia Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 309. Australia Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 310. Australia Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 311. Australia Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 312. Australia Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 313. Australia Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 314. Australia Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 315. South Korea Coccidiosis Vaccines Market Size, 2017-2032 (USD Million)
TABLE 316. South Korea Coccidiosis Vaccines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 317. South Korea Coccidiosis Vaccines Market Size, by Attenuated Live Vaccine, 2017-2032 (USD Million)
TABLE 318. South Korea Coccidiosis Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 319. South Korea Coccidiosis Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 320. South Korea Coccidiosis Vaccines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 321. South Korea Coccidiosis Vaccines Market Size, by Sales Mode, 2017-2032 (USD Million)
TABLE 322. South Korea Coccidiosis Vaccines Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. South Korea Coccidiosis Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 324. Global Coccidiosis Vaccines Market Share, by Key Player, 2025
TABLE 325. Global Coccidiosis Vaccines Market, Key Experts

Companies Mentioned

  • Animalcare Group plc
  • APHA
  • BIMeda, Inc.
  • Bioproperties (Hubei) Biotechnology Co., Ltd.
  • Ceva Santé Animale S.A.
  • CEVAC
  • Elanco Animal Health Incorporated
  • Elanco Operations LLC
  • Hester Biosciences Limited
  • Huvepharma AD
  • IDT Biologika GmbH
  • ImmuCell Corporation
  • Indian Immunologicals Limited
  • Intervet International B.V.
  • Laboratorios Hipra, S.A.
  • Lohmann Animal Health International GmbH
  • Merck Sharp & Dohme Corp.
  • MSD Animal Health UK Limited
  • Pharmaq AS
  • Phibro Animal Health Corporation
  • The Chemo‑Sero‑Therapeutic Research Institute (Kaketsuken)
  • Vaxxinova International BV
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.